COMMUNIQUÉS West-GlobeNewswire

Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates

14/08/2024 - 22:05

Updated clinical results from German Real-World Registry demonstrate potential for Revita ® to meaningfully sustain weight loss and lower blood sugar for at least one-year post-treatment in a real-world setting Granted [...]

Actuate Therapeutics Announces Closing of Initial Public Offering

14/08/2024 - 22:05

CHICAGO and FORT WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”) , a clinical stage biopharmaceutical company focused on developing therapies for the treatment [...]

GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

14/08/2024 - 22:05

GTB-3650 TriKE ® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in 1H 2025 GTB-5550 Phase 1 [...]

Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update

14/08/2024 - 22:05

Positive data from the Phase 2a clinical trial (CLEAR MIND ) evaluating Lomecel-B™ in Alzheimer’s disease presented in Featured Research Oral Presentation at Alzheimer’s Association International Conference ® (AAIC) U.S [...]

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

14/08/2024 - 22:05

- Oral Fadraciclib Phase 2 Proof of Concept Study Enrolling Well - - 065-101 PoC Interim Data Anticipated in the Fourth Quarter of 2024 - - Management to Host Conference Call at 4:30 pm EDT Today - BERKELEY HEIGHTS, N.J [...]

Jushi Holdings Inc. Announces Option Re-Pricing Program

14/08/2024 - 22:05

BOCA RATON, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, is pleased to announce that its [...]

TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update

14/08/2024 - 22:05

FORTH WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug [...]

Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

14/08/2024 - 22:02

- First patient treated in May for liver metastases from colorectal cancer - - Publication in June in Cancers journal of long-term safety and efficacy data in multiple hard-to -treat superficial cancers , with an [...]

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

14/08/2024 - 22:01

Generated 2Q 2024 net FUROSCIX ® revenue of $8.1 million, up 33% sequentially from Q1 Completed financing that extends our cash runway through expected profitability Advanced multiple FUROSCIX growth initiatives [...]

Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update

14/08/2024 - 22:01

Announced plan to initiate Phase 3 VIKTORIA-2 trial evaluating gedatolisib combined with fulvestrant plus a CDK4/6 inhibitor as first-line treatment for patients with HR+, HER2- advanced breast cancer; expect to enroll [...]

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

14/08/2024 - 22:01

Overall response rate (“ORR”) of 25% and 50% disease control rate ("DCR") observed in first four evaluable patients treated with TIDAL-01 with advanced CRC Complete response achieved in heavily pre-treated late line [...]

American Shared Hospital Services Reports Strong Second Quarter 2024 Financial Results

14/08/2024 - 22:01

Revenue increases 27% year over year Reports gain of $3.7 million from strategic acquisition of Rhode Island Radiation Therapy Cancer Centers Now treating patients at the new Puebla, Mexico center Conference Call on [...]

ArriVent BioPharma Reports Second Quarter 2024 Financial Results

14/08/2024 - 22:01

Clinical proof-of-concept monotherapy data for once daily, first-line firmonertinib in EGFR PACC mutant non-small cell lung cancer (NSCLC) to be presented as a presidential symposium presentation at the 2024 World [...]

Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

14/08/2024 - 22:01

– Primary focus continues to be on upcoming results from ENLIGHTEN 1 Phase 3 extension study in 4Q 2024 and ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients in 1H 2025, as planned – – In parallel, the company continues [...]

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

14/08/2024 - 22:01

TX45 advances into Phase 2 clinical trial for patients with Group 2 PH-HFpEF with first site activated and screening open in August 2024 Received U.S. Investigational New Drug (IND) clearance for lead program, TX45 in [...]

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

14/08/2024 - 22:00

EDEN PRAIRIE, Minn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and [...]

Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update

14/08/2024 - 22:00

Second quarter net product revenues for ZORYVE ® franchise of $30.9M, with $17.3M for ZORYVE (roflumilast) cream 0.3%, and $13.6M for ZORYVE (roflumilast) topical foam, 0.3%; sales growth of 547% vs. Q2 '23 and 43% vs. [...]

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

14/08/2024 - 20:30

SP-26 dissolvable ketamine-based injectable implant targets chronic pain and fibromyalgia Sever Pharma to scale-up extrusion processes and continue analytical testing for novel non-opioid treatment SARASOTA, FL, Aug. 14 [...]

Decisely Celebrates its Place on the 2024 Inc. 5000 List of Fastest-Growing Private Companies

14/08/2024 - 20:30

ALPHARETTA, GA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Decisely, a leading provider of health benefits and management solutions for business owners, is proud to announce its inclusion in the prestigious Inc. 5000 list for [...]